Cell Cure Neurosciences Ltd. announced that it will receive $5,000,000 in funding from existing investor, Hadasit Bio-Holdings, Ltd. on March 31, 2016. The company will issue convertible loan in the transaction.
HBL - Hadasit Bio-Holdings Ltd TEL AVIV STOCK EXCHANGE
Equities
HDST
IL0010954050
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |